As part of our recent Spotlight focus on biosimilars in oncology, we asked you to share your thoughts and opinions on the role of biosimilars in oncology. Thanks to all who shared your thoughts with us – the results have been translated into this summary infographic.
Browsing: Taxonomy > Drug development
Listen to this exclusive interview with Peter Stern (University of Manchester, UK) to discover more about chemotherapy resistance in acute lymphoblastic leukemia and novel strategies to overcome it.
A group of researchers have uncovered a link between chemo-resistance in pediatric acute lymphoblastic leukaemia and the protein 5T4; early-testing indicates that targeting the protein could help improve treatment outcomes.
This article outlines how heat change can influence magnetic nanoparticles in cancer therapy, it covers the magnetic nanoparticle, thermal therapy, heat performance and future prospectives.
In this exclusive interview, Gopalan Narayanan from Voisin Consulting Life Sciences (UK), speaks about whether there are sufficient resources available to clinicians looking to adopt biosimilar’s, regulatory challenges during ATMP development and the potential of both of these products to transform the treatment of complex diseases.
This primary research paper investigated the anti-cancer efficacy and pharmacokinetics of tamoxifen conjugated to glycinated fullerenes
This article summarizes the outcome of a randomized phase III clinical trial investigating the effect of FLT3 inhibitors to improve FTL3-mutated acute myeloid leukemia